- Home
- BTBD vs BDRX Comparison
BTBD vs BDRX Comparison
Compare BTBD & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTBD
- BDRX
- Stock Information
- Founded
- BTBD 1987
- BDRX 2000
- Country
- BTBD United States
- BDRX United Kingdom
- Employees
- BTBD N/A
- BDRX 13
- Industry
- BTBD Restaurants
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- BTBD Consumer Discretionary
- BDRX Health Care
- Exchange
- BTBD Nasdaq
- BDRX Nasdaq
- Market Cap
- BTBD 9.1M
- BDRX 3.9M
- IPO Year
- BTBD 2021
- BDRX N/A
- Fundamental
- Price
- BTBD $1.63
- BDRX $6.71
- Analyst Decision
- BTBD
- BDRX
- Analyst Count
- BTBD 0
- BDRX 0
- Target Price
- BTBD N/A
- BDRX N/A
- AVG Volume (30 Days)
- BTBD 6.2M
- BDRX 53.1K
- Earning Date
- BTBD 11-12-2025
- BDRX 09-23-2025
- Dividend Yield
- BTBD N/A
- BDRX N/A
- EPS Growth
- BTBD N/A
- BDRX N/A
- EPS
- BTBD N/A
- BDRX N/A
- Revenue
- BTBD $14,533,449.00
- BDRX N/A
- Revenue This Year
- BTBD N/A
- BDRX N/A
- Revenue Next Year
- BTBD N/A
- BDRX N/A
- P/E Ratio
- BTBD N/A
- BDRX N/A
- Revenue Growth
- BTBD 1.58
- BDRX N/A
- 52 Week Low
- BTBD $1.00
- BDRX $5.00
- 52 Week High
- BTBD $5.60
- BDRX $108.90
- Technical
- Relative Strength Index (RSI)
- BTBD 44.69
- BDRX 55.69
- Support Level
- BTBD $1.61
- BDRX $5.81
- Resistance Level
- BTBD $2.00
- BDRX $6.47
- Average True Range (ATR)
- BTBD 0.38
- BDRX 0.51
- MACD
- BTBD -0.07
- BDRX 0.22
- Stochastic Oscillator
- BTBD 1.03
- BDRX 81.44
About BTBD BT Brands Inc.
BT Brands Inc operates and owns a fast-food restaurant called Burger Time. The company also operates in Minnesota as a franchisee of Dairy Queen. It offers a variety of burgers and other affordably priced foods such as chicken sandwiches, pulled pork sandwiches, chicken chunks, side dishes, and soft drinks.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.